Human IFN-α protein engineering:: The amino acid residues at positions 86 and 90 are important for antiproliferative activity

被引:26
作者
Hu, RQ [1 ]
Bekisz, J
Schmeisser, H
McPhie, P
Zoon, K
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA
[2] NIDDKD, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.167.3.1482
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human IFN-alpha is a family of structurally related proteins that exhibit a wide range of antiproliferative activities. To understand the structural basis for these different antiproliferative activities, eight recombinant human IFN-alpha hybrids (HY) of alpha 21a/alpha 2c (HY-4, HY-5) and mutants (site-directed mutagenesis (SDM)-1, 2 and cassette mutagenesis (CM)-1, 2, 3, and 4) have been expressed, purified, and characterized. The data showed that the amino acid region 81-95 is important for antiproliferative activity. Site-directed mutagenesis and cassette mutagenesis studies showed that if serine (S) 86 and asparagine (N) 90 were replaced by tyrosine (Y), the antiproliferative activity was increased. We have also observed that if Y86 was replaced by isoleucine (I), the antiproliferative activity was comparable. However, if Y86 was replaced by aspartic acid (D), lysine (K), or alanine (A), the antiproliferative activity was substantially decreased. Our results indicate that Y and/or I at position 86 and Y at position 90 are very important in antiproliferative activity of human IFN-alpha. Circular dichroism spectra showed that the amino acid replacements at position 86 did not change the secondary structure. Thus the biological activity changes among those mutants do not appear to be due to conformational changes. The results also suggest that hydrophobic residue(s) at position 86 may be important for the interaction of the molecule with its receptor. The competitive binding data correlated with the antiproliferative activity. The N-terminal region of the molecule and the hydrophobic residues (including Y and I) on the C-helix region at positions 86 and/or 90 are important for binding and antiproliferative activities of human ifn-alphas..
引用
收藏
页码:1482 / 1489
页数:8
相关论文
共 38 条
[1]   STRUCTURE-FUNCTION STUDIES OF HUMAN INTERFERONS-ALPHA - ENHANCED ACTIVITY ON HUMAN AND MURINE CELLS [J].
CHEETHAM, BF ;
MCINNES, B ;
MANTAMADIOTIS, T ;
MURRAY, PJ ;
ALIN, P ;
BOURKE, P ;
LINNANE, AW ;
TYMMS, MJ .
ANTIVIRAL RESEARCH, 1991, 15 (01) :27-40
[2]   STRUCTURE OF THE HUMAN INTERFERON-ALPHA RECEPTOR [J].
COLAMONICI, OR ;
PFEFFER, LM .
PHARMACOLOGY & THERAPEUTICS, 1991, 52 (02) :227-233
[3]  
CUTRONE EC, 2000, EUR CYTOKINE NETW, V11, P60
[4]   MUTATIONAL ANALYSIS OF THE STRUCTURE-FUNCTION RELATIONSHIP IN INTERFERON-ALPHA [J].
DIMARCO, S ;
GRUTTER, MG ;
PRIESTLE, JP ;
HORISBERGER, MA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (03) :1445-1451
[5]   CLONING AND EXPRESSION OF A LONG FORM OF THE BETA-SUBUNIT OF THE INTERFERON ALPHA-BETA RECEPTOR THAT IS REQUIRED FOR SIGNALING [J].
DOMANSKI, P ;
WITTE, M ;
KELLUM, M ;
RUBINSTEIN, M ;
HACKETT, R ;
PITHA, P ;
COLAMONICI, OR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21606-21611
[6]   DEFINITION OF RECEPTOR-BINDING DOMAINS IN INTERFERON-ALPHA [J].
FISH, EN .
JOURNAL OF INTERFERON RESEARCH, 1992, 12 (04) :257-266
[7]   INTERFERON-ALPHA HYBRIDS [J].
HORISBERGER, MA ;
DIMARCO, S .
PHARMACOLOGY & THERAPEUTICS, 1995, 66 (03) :507-534
[8]   ENGINEERING HYBRID GENES WITHOUT THE USE OF RESTRICTION ENZYMES - GENE-SPLICING BY OVERLAP EXTENSION [J].
HORTON, RM ;
HUNT, HD ;
HO, SN ;
PULLEN, JK ;
PEASE, LR .
GENE, 1989, 77 (01) :61-68
[9]  
HU R, 1994, J INTERFERON RES, V14, pS98
[10]  
Hu RQ, 1999, J IMMUNOL, V163, P854